Kegg medicus dgroup
| DG01526 | |
| DG番号 | DG01526 |
| 分類 | DGroup |
| 名称 | Topoisomerase I inhibitor TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG00725 Topotecan D08618 Topotecan (BAN) D02168 Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN) DG00726 Irinotecan D08086 Irinotecan (INN) D01061 Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP18) D10642 Irinotecan sucrosofate (USAN) DG01267 Etirinotecan pegol D10367 Etirinotecan pegol (USAN/INN) D10422 Etirinotecan pegol tetrahydrochloride (USAN) D10427 Etirinotecan pegol tetratriflutate (USAN) D03225 Belotecan hydrochloride (USAN) D01432 Exatecan mesylate (USAN); Exatecan mesilate hydrate (JAN) D03954 Edotecarin (USAN/INN) D04031 Rubitecan (USAN/INN) D04822 Lurtotecan dihydrochloride (USAN) D05385 Pegamotecan (USAN) D09327 Cositecan (USAN) D09679 Tenifatecan (USAN/INN) D10464 Firtecan pegol (USAN/INN) |
| 上位グループ | Antineoplastic DG01529 Topoisomerase inhibitor |
| 注釈1 | ATC code: L01CE |
| 注釈2 | Antineoplastic |